ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen " ASCO 2025 Plenary - MATTERHORN"
Episode Synopsis
This week’s episode will be focusing on one of the GI plenary session abstracts presented at the ASCO Annual Meeting 2025, the MATTERHORN trial: phase 3 durvalumab + FLOT which is 5FU leucovorin, oxaliplatin and docetaxel in resectable gastric or GE junction CA.
More episodes of the podcast Two Onc Docs
Hodgkin Lymphoma 2025 UPDATE
24/11/2025
Anal Cancer 2025 UPDATE
17/11/2025
Urothelial ESMO 2025 Updates
10/11/2025
Board Review Tidbits
03/11/2025
Porphyria
27/10/2025
Metastatic Breast Cancer 2025 UPDATE
20/10/2025
Localized Breast Cancer 2025 UPDATE
13/10/2025
In God we trust